Quinazoline based EGFR inhibitors

Details for Australian Patent Application No. 2007296745 (hide)

Owner Curis, Inc.

Inventors Cai, Xiong; Qian, Changgeng

Agent Pizzeys

Pub. Number AU-B-2007296745

PCT Pub. Number WO2008/033748

Priority 60/843,644 11.09.06 US; 60/895,873 20.03.07 US

Filing date 10 September 2007

Wipo publication date 20 March 2008

Acceptance publication date 1 December 2011

International Classifications

C07C 211/39 (2006.01) Compounds containing amino groups bound to a carbon skeleton

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

C07D 239/94 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/033748 Priority application(s): WO2008/033748

17 September 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Quinazoline based EGFR inhibitors

1 December 2011 Application Accepted

  Published as AU-B-2007296745

29 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007296746-Quinazoline based EGFR inhibitors containing a zinc binding moiety

2007296744-Multi-functional small molecules as antiproliferative agents